Also, as previously announced, Synaptogenix will hold a conference call for investors to discuss its abstract. The call will take place, today, Monday, July 26th at 4:15pm ET and will be hosted by the Company’s Chief Executive Officer, Dr. Alan Tuchman, and its President and Chief Science Officer, Dr. Daniel Alkon. Drs. Tuchman and Alkon will take live Q&A following their prepared remarks.
The U.S. toll free dial-in for the conference call is (877) 407-9205, and the international dial-in number is 1-(201)-689-8054. A live webcast of the conference call will also be available via: https://www.webcaster4.com/Webcast/Page/2599/42216.
